Consumer spending ‘will soften’ in 2024, CFRA analyst says

Consumer goods companies have been a hot topic of discussion amongst investors ever since Goldman Sachs predicted that the global weight loss drug market could become a $100 billion market by 2030. However, after Walmart (WMT) warned these drugs could be impacting its food sales, some investors became concerned about what it could mean for food-related stocks. Arun Sundaram, CFRA Analyst, joins Yahoo Finance to discuss the impact GLP-1 drugs have had on the market and whether investors should continue to be worried about the growing trend in its use.
Sundaram says plainly: “I think the near-term reaction to these GLP-1 drugs are bit overblown, if you look at the stocks for a lot of consumer-related names, a lot of food-related names, they are down significantly ever since that topic became pretty popular a few months ago but, that’s something that all companies are monitoring still. It’s too early to tell the exact impact in terms of food and beverage consumption.”
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
Connect with Yahoo Finance:
Check the latest news and data at finance.yahoo.com

Follow Yahoo Finance on social:
Connect with Yahoo Finance:
Get the latest news: https://yhoo.it/2fGu5Bb
Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq
Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP
Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz
Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV